Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-13 17:21:36 ET
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST
Company Participants
Stephanie Cornen - Vice President of Investor Relations, Communication & Commercial Strategy
Jonathan Dickinson - CEO & Director
Sonia Quaratino - Executive VP & Chief Medical Officer
...
Read the full article on Seeking Alpha
For further details see:
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call Transcript
Innate Pharma - Class A
NASDAQ: IPHYF
IPHYF Trading
-63.76% G/L:
$2.155 Last:
100 Volume:
$2.155 Open:
IPHYF Latest News
February 19, 2026 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 18, 2026 01:00:00 am
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
December 22, 2025 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
IPHYF Stock Data
$160,353,438
44,923,628
N/A
20
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille
